Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy

Clinical trial NCT06809751 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06809751
Sponsor: Mohsen Pourazizi
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Central Serous Chorioretinopathy Melatonin Ocular Diseases Visual Acuity Macula Abnormality

Start date: 2025-02-01
Primary completion: 2025-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.